Table 3

Equality of opportunity and causes of mortality

Attainment of bottom quartileAttainment of top quartileCorrelation of parental and children’s attainment
β (CI 95%)R2 β (CI 95%)R2 β (CI 95%)R2
Infectious and parasitic diseasesM1: −0.22 (−0.70 to 0.25)0.18M1: 0.35† (−0.01 to 0.71)0.18M1: 0.20† (−0.01 to 0.40)0.18
Malignant neoplasmsM2: −0.14† (−0.28 to 0.01)0.07M2: 0.19* (0.06 to 0.32)0.07M2: 0.07† (−0.00 to 0.14)0.07
Endocrine, nutritional and metabolic diseasesM3: −0.23 (−0.55 to 0.08)0.23M3: −0.04 (−0.36 to 0.29)0.23M3: 0.11 (−0.03 to 0.25)0.23
Mental and behavioural disordersM4: −0.15 (−0.91 to 0.62)0.13M4: 0.38 (−0.48 to 1.24)0.14M4: 0.09 (−0.31 to 0.49)0.13
Diseases of the nervous system and the sense organsM5: − 0.28* (−0.48 to 0.09)0.24M5: 0.19 (−0.04 to 0.42)0.24M5: 0.16* (0.06 to 0.26)0.24
Diseases of the circulatory systemM6: −0.14 (−0.29 to 0.01)0.20M6: 0.21† (0.02 to 0.39)0.20M6: 0.08 (−0.02 to 0.18)0.20
Diseases of the respiratory systemM7: −0.46* (−0.76 to 0.16)0.26M7: 0.46* (0.18 to 0.74)0.26M7: 0.28* (0.14 to 0.42)0.27
External causes of morbidity and mortalityM8: − 0.25* (−0.44 to to 0.07)0.17M8: 0.24† (−0.01 to 0.48)0.17M8: 0.14† (0.02 to 0.25)0.17

  • Total number of observations is 1200. CIs are computed using heteroskedasticity-robust SEs corrected for clustering at the age group-year level. Regressions are population weighted. Regressors from ESS are additionally design-weighted. All models include year, age group and country fixed effects and all controls described in Methods section and in table 1. Reported R2 are 'within' R2. Significant associations (uncorrected, at 5% level) are shown in bold.

  • Analyses were conducted using the REGHDFE Stata package.42

  • *Significant at table-wide false discovery rate of 5% (using Benjamini-Hochberg method).

  • †Significant at a table-wide false discovery rate of 10%.

  • ESS, European Social Survey.